Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe

Journal of Drug Targeting

Volumn 18, Issue 7, 2010, Pages 506-519

  Bali, Vikas ^a   Ali, Mushir ^a   Ali, Javed ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Ezetimibe; Nanoemulsion; Oral bioavailability; Pseudoternary phase diagram; Stability

Indexed keywords

CHOLESTEROL; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; EZEDOC; EZETIMIBE; GLYCERYL MONOLINOLEATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LABRASOL; LIPID; MACROGOL 400; OLEOYLMACROGOGLYCERIDE; POLYSORBATE 20; POLYSORBATE 80; PROPYLENE GLYCOL; PROPYLENE GLYCOL DICAPRYLOCAPRYLATE; PROPYLENE GLYCOL LAURATE; PROPYLENE GLYCOL MONOCAPRYLATE; PROPYLENE GLYCOL MONOCAPRYLIC ESTER; PROPYLENE GLYCOL MONOLAURATE; TRIACETIN; UNCLASSIFIED DRUG; WATER OIL CREAM; AZETIDINE DERIVATIVE; EMULSION; EXCIPIENT; HYPOCHOLESTEROLEMIC AGENT; NANOPARTICLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; MAXIMUM PLASMA CONCENTRATION; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; REFRACTION INDEX; ROOM TEMPERATURE; SHELF LIFE; STORAGE TEMPERATURE; THERMOSTABILITY; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY; ZETA POTENTIAL; ANIMAL; BIOAVAILABILITY; CHEMISTRY; COMPARATIVE STUDY; EMULSION; METABOLISM; SOLUBILITY; THERMODYNAMICS; WISTAR RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AZETIDINES; BIOLOGICAL AVAILABILITY; CHOLESTEROL; DRUG STABILITY; DRUG STORAGE; EMULSIONS; EXCIPIENTS; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; SOLUBILITY; THERMODYNAMICS;

EID: 77954256928     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903548362     Document Type: Article

References (26)

1. Ahmed M, Ramadan W, Rambhu D, Shakeel F. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie, 63: 806-811.
2. Ambike AA, Mahadik KR, Paradkar A. (2005). Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations. Pharm Res, 22: 990-998.
3. Attwood D, Mallon C, Taylor CJ. (1992). Phase studies on oil-in-water phospholipid microemulsions. Int J Pharm, 84: R5-R8.
4. Basha SJ, Naveed SA, Tiwari NK, Shashikumar D, Muzeeb S, Kumar TR, Kumar NV, Rao NP, Srinivas N, Mullangi R, Srinivas NR. (2007). Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: quantitative application to various in vitro metabolic stability studies and for qualitative estimation in bile. J Chromatogr B Analyt Technol Biomed Life Sci, 853: 88-96.
5. Bolkent S, Yanardag R, Karabulut-Bulan O, Yesilyaprak B. (2005). Protective role of Melissa ofcinalis L. extract on liver of hyperlipidemic rats: a morphological and biochemical study. J Ethnopharmacol, 99: 391-398.
6. Constantinides PP.(1995). Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceuti-cal aspects. Pharm Res. 12, 1561-1572.
7. Dixit RP, Nagarsenker MS. (2008a). Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci, 35: 183-192.
8. Dixit RP, Nagarsenker MS. (2008b). Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm, 34: 1285-1296.
9. Doshi AS, Kachhadia PK, Joshi HS. (2008). Validation of a stability-indicating LC method for assay of ezetimibe in tablets and for determination of content uniformity. Chromatographia, 67: 137-142.
10. Ezzet F, Krishna G, Wexler DB, Statkevich P, Kosoglou T, Batra VK. (2001). A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe. Clin Ter, 23: 871-885.
11. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. (1966). Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep, 50: 219-244
12. Ghosh MN, ed. (2005). Fundamentals of Experimental Pharmacology (p. 192). Chapter 30. Toxicity studies. Kolkata: Hilton and Company Publishers.
13. Ghosh PK, Murthy RS. (2006). Microemulsions: a potential drug delivery system. Curr Drug Deliv, 3: 167-180.
14. Jeu L, Cheng JW. (2003). Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor. Clin Ter, 25: 2352-2387.
15. Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm, 274: 65-73.
16. Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Alton KB. (2005). Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet, 44: 467-494.
17. Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev, 45: 89-121.
18. Lipka LJ. (2003). Ezetimibe: a frst-in-class, novel cholesterol absorption inhibitor. Cardiovasc Drug Rev, 21: 293-312.
19. Nerurkar MM, Burton PS, Borchardt RT. (1996). Te use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efux system. Pharm Res, 13: 528-534.
20. Patel R, Bhimani D, Patel J, Patel D. (2008). Solid-state characterization and dissolution properties of ezetimibe-cyclodextrins inclusion complexes. J Incl Phenom Macro, 60: 241-251.
21. Patel AR, Vavia PR. (2007). Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofbrate. AAPS J, 9: E344-E352.
22. Patrick JE, Kosoglou T, Stauber KL, Alton KB, Maxwell SE, Zhu Y, Statkevich P, Iannucci R, Chowdhury S, Afrime M, Cayen MN. (2002). Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects. Drug Metab Dispos, 30: 430-437.
23. Pouton CW. (1997). Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev, 25: 47-58.
24. Shafq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. (2007). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm, 66: 227-243. (Pubitemid 46667230)
25. Sistla R, Tata VS, Kashyap Y V, Chandrasekar D, Diwan P V. (2005). Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms. J Pharm Biomed Anal, 39: 517-522
26. Vyas SP, Khar RK, eds. (2002). Targeted and Controlled Drug Delivery (p. 280). Chapter 7. Submicronemulsions. New Delhi: CBS Publishers.